期刊文献+

Screen biomarkers of human lung squamous carcinoma by serological proteome analysis of HTB-182

Screen biomarkers of human lung squamous carcinoma by serological proteome analysis of HTB-182
下载PDF
导出
摘要 Carcinogenesis of lung squamous carcinoma is a complex process involving multiple events and steps. At present, there are very few special lung cancer molecular markers for an 'early-stage' diagnosis and prognosis evaluation. To identify tumor-associated antigens, serological proteome analysis (SERPA) of human lung squamous carcinoma cell line HTB-182 are performed. We characterized sixteen differentially expressed proteins which react with lung squamous carcinoma patient sera while not react with control sera. Some of these candidate lung squamous carcinoma-associated antigens were metabolic enzymes, such as triosephosphatase isomerase (TPIS). Some proteins were involved in the regulation of cell cycle and signal transduction. The results will provide scientific foundation for screening the molecular biomarkers used to diagnose and treat lung squamous carcinoma, as well as to elevate the patient's prognosis and provide new clue for the research of lung squamous carcinogenic mechanism. Thus, SERPA represents a valuable approach for the identification of differentially expressed proteins, which might be used as markers for the diagnosis and prognosis of lung squamous carcinoma. Carcinogenesis of lung squamous carcinoma is a complex process involving multiple events and steps. At present, there are very few special lung cancer molecular markers for an "early-stage" diagnosis and prognosis evaluation, To identify tumor-associated antigens, serological proteome analYsis (SERPA) of human lung squamous carcinoma cell line HTB-182 are performed. We characterized sixteen differentially expressed proteins which, react with lung squamous carcinoma patient sera while not react with control sera. Some of these candidate lung squamous carcinoma-associated antigens were metabolic enzymes, such as triosephosphatase isomerase (TPIS). Some proteins were involved in the regulation of cell cycle and signal transduction. The results will provide scientific foundation for screening the molecular biomarkers used to diagnose and treat lung squamous carcinoma, as well as to elevate the patient's prognosis and provide new clue for the research of lung squamous carcinogenic mechanism. Thus, SERPA represents a valuable approach for the identification of differentially expressed proteins, which might be used as markers for the diagnosis and prognosis of lung squamous carcinoma.
出处 《中国有色金属学会会刊:英文版》 CSCD 2006年第B02期839-844,共6页 Transactions of Nonferrous Metals Society of China
基金 Project (2001CB5102) supported by the National Basic Research Program of China Project (30500558) supported by the National Natural Science Foundation of China
关键词 人肺鳞癌 HTB-182细胞系 血清蛋白质组学分析 生物标记物 biomarker HTB-182 SERPA 2-DE MALDI-TOF-MS
  • 相关文献

参考文献15

  • 1LOPEZ A D. Counting the dead in China: measuring tobacco'simpact in the developing world[J]. Br Meal J ,1998, 317: 1399.
  • 2LE NAOUR E Contribution of proteomics to tumor immunology[J].Proteomics, 2001,1(10): 1295-1300.
  • 3SELIGER B, KELLNER R. Design of proteome-based studies incombination with serology for the identification of biomarkers andnovel targets[J]. Proteomics, 2002, 2(12): 1645-1651.
  • 4STOCKERT E, JAGER E, CHEN Y T, SCANLAN M J, GOUT I,KARBACH J, ARAND M, KNUTH A, OLD L J. A survey ofhumoral immune response of cancer patients to a panel of humantumor antigens[J]. J Exp Med, 1998, 187:1349-1354.
  • 5NAOUR F L, BRICHORY F, BERETTA L, HANASH S M.Identification of Tumor-Associated antigen using proteomics[J].Technology In Cancer Research and Treatment, 2002, 1(4):257-262.
  • 6NAOUR F L, BRICHORY F, MISEK D E, BRECHOT C, HANASHS M, BERETTA L. A distinct repertoire of autoantibodies inhepatocellular carcinoma identified by proteomie analysis[J].Molecular & Cellular Proteomies, 2002, 1(3): 197-203.
  • 7KELLNER S, LICHTENFELS R, ATKINS D, BUKUR J,ACKERMANN A, BECK J, BRENNER W, MELCHIOR S,SELIGER B. Targeting of tumor associated antigens in renal cellcarcinoma using proteome-based analysis and their clinicalsignificance[J]. Protenmics, 2002, 2( 12): 1743-1751.
  • 8LE NAOUR-F,-- MISEK D E, KRAUSE M C, DENEUX L,GIORDANO T J, SCHOLL S, HANASH S M. Protenmics-basedidentification of RS/DJ-1 as a novel circulating tumor antigen inbreast cancer[J]. Clin Cancer Res, 2001, 7(11): 3328-3335.
  • 9PRASANNAN L, MISEK D E, HINDERER R, MICHON J,GEIGER J D, HANASH S M. Identification of beta-tubulin isoforms as tumor antigens in neuroblastoma[J]. Clin Cancer Res, 2000, 6(10):3439-3456.
  • 10BRICHORY F, BEER D, LIE NAOUR F, GIORDANO T, HANASHS. Proteomics-based identification of protein gene product 9.5 as atumor antigen that induces ahumoral immune response in lungcancer[J]. Cancer Res, 2001,61 (21): 7908-7912.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部